Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)-A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov.

Publication

Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)-A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov.

Journal Paper/Review - Mar 23, 2023

Ukegjini Kristjan, Guidi Marisa, Lehmann Kuno, Süveg Krisztian, Putora Paul Martin, Cihoric Nikola, Steffen Thomas

Citation

Ukegjini K, Guidi M, Lehmann K, Süveg K, Putora P, Cihoric N, Steffen T. Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)-A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov. Cancers (Basel) 2023; 15

Type

Journal Paper/Review (English)

Journal

Cancers (Basel) 2023; 15

Publication Date

Mar 23, 2023

Issn Print

2072-6694

Brief description/objective

Over the past two decades, cytoreductive surgery and HIPEC has improved outcomes for selected patients with peritoneal metastasis from various origins. This is a cross-sectional study with descriptive analyses of HIPEC trials registered on ClinicalTrials.gov. This study aimed to characterize clinical trials on HIPEC registered on ClinicalTrials.gov with the primary objective of identifying a trial focus and to examine whether trial results were published.